Boceprevir

Also known as: SCH 503034, EBP 520, Victrelis, (1R,2S,5S)-N-(4-Amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide, Sch 503034, EBP-520, SCH-503034, CS-354

Boceprevir (CAS 394730-60-0) is a compound in the Organic Compounds category listed in the Jingsj chemical database. It has the molecular formula C27H45N5O5 and a molecular weight of 519.677 g/mol. Key property: a density of 1.2±0.1 g/cm3. No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.

CAS No.: 394730-60-0
Jingsj CID: J-1986971-7
Molecular Formula: C₂₇H₄₅N₅O₅
Molecular Weight: 519.677 g/mol
Category: Organic Compounds
Last updated: 8/21/2026

Request MSDS / TDS

No offers for this compound yet.

Request a quote

Physicochemical Properties

Density	1.2±0.1 g/cm3
Exact Mass	519.342041
PSA	150.70000
LogP	2.05
Refractive Index	1.533
Storage Conditions	-20℃

Activity & Biological Data

Target	Ki: 14 nM (HCV NS3 protease)[1]
Additional Information	[1]. Njoroge FG, et al. Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection. Acc Chem Res. 2008 Jan;41(1):50-9. [2]. Yao M, et al. Conditional Inducible Triple-Transgenic Mouse Model for Rapid Real-Time Detection of HCV NS3/4A ProteaseActivity. PLoS One. 2016 Mar 4;11(3):e0150894. [3]. Coilly A, et al. Practical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrence. Antimicrob Agents Chemother. 2012 Nov;56(11):5728-34. [4]. Berenguer M, et al. New developments in the management of hepatitis C virus infection: focus on boceprevir. Biologics. 2012;6:249-56. [5]. Burton MJ, et al. Telaprevir and boceprevir in african americans with genotype 1 chronic hepatitis C: implications for patients and providers. South Med J. 2012 Aug;105(8):431-6.

Target

Ki: 14 nM (HCV NS3 protease)[1]

Additional Information

[1]. Njoroge FG, et al. Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection. Acc Chem Res. 2008 Jan;41(1):50-9. [2]. Yao M, et al. Conditional Inducible Triple-Transgenic Mouse Model for Rapid Real-Time Detection of HCV NS3/4A ProteaseActivity. PLoS One. 2016 Mar 4;11(3):e0150894. [3]. Coilly A, et al. Practical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrence. Antimicrob Agents Chemother. 2012 Nov;56(11):5728-34. [4]. Berenguer M, et al. New developments in the management of hepatitis C virus infection: focus on boceprevir. Biologics. 2012;6:249-56. [5]. Burton MJ, et al. Telaprevir and boceprevir in african americans with genotype 1 chronic hepatitis C: implications for patients and providers. South Med J. 2012 Aug;105(8):431-6.

Frequently Asked Questions

What is the CAS number of Boceprevir?

The CAS number of Boceprevir is 394730-60-0.

What are the molecular formula and molecular weight of Boceprevir?

Boceprevir has molecular formula C27H45N5O5 and molecular weight 519.677 g/mol.

What are the upstream and downstream products of Boceprevir?

For Boceprevir, Upstream Products: (1R,2S,5S)-3-((S)-2-(3-tert-butylureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid, 3-Amino-4-cyclobutyl-2-oxobutanamide hydrochloride, tert-butyl (1-cyclobutyl-3-oxopropan-2-yl)carbamate.

Data compiled from public chemical databases such as PubChem and supplier catalogs; supplier offers are provided by suppliers.

Last updated: 8/21/2026

How to cite: Jingsj. "Boceprevir (CAS 394730-60-0)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-1986971-7 (accessed 2026-11-09).

Data for reference only; verify product details with suppliers before purchase.